Delivery Order 75N92019D00016-75N92021F00001
Award Date 12/11/20
Potential Completion Date 1/21/22
Potential Value $1.5M
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost No Fee
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract, valued at $1,677,614.67, is for the Gene Therapy Resource Program (GTRP), which supports translational gene therapy research by providing resources and services from three core laboratories: the Pharmacology and Toxicology Core Laboratory, the...
- This is a delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to The Trustees of the University of Pennsylvania (Penn) to support the Gene Therapy Resource Program (GTRP). The $1,671,379.55 cost-no-fee contract is for Penn's Preclinical Vector Core Laboratory to provide scientific activities related to gene therapy. The award has a completion date of July 5, 2024 and does not have a set-aside designation. Penn is a leading private research university...
- This federal contract award, valued at $213,371, was issued by the National Heart Lung and Blood Institute (NHLBI) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The award is for the Gene Therapy Resource Program (GTRP), Task Area A, which involves core administrative tasks. The contract is a Delivery Order with a Cost No Fee pricing type, with a period of performance ending on June 30, 2024. The award does not...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Delivery Order to The Trustees of the University of Pennsylvania (Penn) on August 23, 2019 with a potential value of $1,408,152.00 for "TASK AREA B: PRE-CLINICAL VECTOR CORE LABORATORY SCIENTIFIC ACTIVITIES" under the Gene Therapy Resource Program (GTRP). This is a Cost No Fee contract with a completion date of September 22, 2021. Penn is a private university...
- This $14,424.00 firm fixed-price purchase order was awarded by the National Human Genome Research Institute, a civilian agency within the U.S. Department of Health and Human Services, to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The award, which does not have a set-aside designation, is described as QTE#27207 and has an ultimate completion date of August 11, 2023. The University of Pennsylvania is a renowned private...
- The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $18,371.00 firm-fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract is for the NHLBI's DIR Graft Lungevity Study, which requires obtaining samples and data. The contract has an ultimate completion date of August 31, 2025 and was awarded on September...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $15,143 firm fixed price purchase order to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract is to be performed in Philadelphia, Pennsylvania over a one day period from July 24, 2023 through July 24, 2023. No additional details were provided on products or services requested under the...
- The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, has been awarded a $10,447 firm fixed price purchase order by the National Institutes of Health's National Cancer Institute. The contract calls for tuition payment required per the terms of a memorandum of understanding between NIH and the University of Pennsylvania for trainee Kyle Rekedal. Several supporting documents were provided. Funding is provided by the Department of...
- This is a definitive cost-no-fee contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian federal agency, to the Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The $12,427,447.18 contract is for a randomized clinical trial of genotype-guided dosing of warfarin therapy. The contract does not have a set-aside designation, reflecting the University of Pennsylvania's status as a large research...
- This is a federal contract awarded to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, by an unspecified U.S. government agency. The contract is a definitive, cost-no-fee contract with a potential value of $3,349,465.00. The place of performance is Pennsylvania, USA, and the contract does not have a set-aside designation. The Trustees of the University of Pennsylvania is a private university and non-profit organization...